These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25144989)

  • 1. Irritable bowel syndrome in Croatia.
    Grubić P; Jurcić D; Ebling B; Gmajnić R; Nikolić B; Pribić S; Bilić A; Levak MT
    Coll Antropol; 2014 Jun; 38(2):565-70. PubMed ID: 25144989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthropological, demographic and socioeconomic characteristics of irritable bowel syndrome.
    Ebling B; Jurcić D; Gmajnić R; Vcev A; Bilić A; Pribić S
    Coll Antropol; 2011 Jun; 35(2):513-21. PubMed ID: 21755726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of irritable bowel syndrome in Croatia.
    Baretić M; Bilić A; Jurcić D; Mihanović M; Sunić-Omejc M; Dorosulić Z; Restek-Petrović B
    Coll Antropol; 2002 Dec; 26 Suppl():85-91. PubMed ID: 12674839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irritable bowel syndrome: a population based study.
    Khoshkrood-Mansoori B; Pourhoseingholi MA; Safaee A; Moghimi-Dehkordi B; Sedigh-Tonekaboni B; Pourhoseingholi A; Habibi M; Zali MR
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):413-8. PubMed ID: 20076812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of irritable bowel syndrome in Korea: population-based survey using the Rome II criteria.
    Han SH; Lee OY; Bae SC; Lee SH; Chang YK; Yang SY; Yoon BC; Choi HS; Hahm JS; Lee MH; Lee DH; Kim TH
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1687-92. PubMed ID: 16984590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demographic, anthropometric and socioeconomic characteristics of functional constipation in Eastern Croatia.
    Ebling B; Gulić S; Jurcić D; Martinac M; Gmajnić R; Bilić A; Pribić S; Levak MT
    Coll Antropol; 2014 Jun; 38(2):539-46. PubMed ID: 25144985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the 'true' prevalence of irritable bowel syndrome?
    Sperber AD; Shvartzman P; Friger M; Fich A
    Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):441-7. PubMed ID: 17489053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of celiac disease among pediatric patients with irritable bowel syndrome: a 6-year prospective cohort study.
    Cristofori F; Fontana C; Magistà A; Capriati T; Indrio F; Castellaneta S; Cavallo L; Francavilla R
    JAMA Pediatr; 2014 Jun; 168(6):555-60. PubMed ID: 24756157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study.
    Yilmaz S; Dursun M; Ertem M; Canoruc F; Turhanoğlu A
    Int J Clin Pract; 2005 Mar; 59(3):361-9. PubMed ID: 15857337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The epidemiology of irritable bowel syndrome in Denmark. A population-based survey in adults ≤50 years of age.
    Krogsgaard LR; Engsbro AL; Bytzer P
    Scand J Gastroenterol; 2013 May; 48(5):523-9. PubMed ID: 23506174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological features of irritable bowel syndrome in a Turkish urban society.
    Celebi S; Acik Y; Deveci SE; Bahcecioglu IH; Ayar A; Demir A; Durukan P
    J Gastroenterol Hepatol; 2004 Jul; 19(7):738-43. PubMed ID: 15209618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An epidemiologic study of irritable bowel syndrome among adolescents in China].
    Li DG; Zhou HQ; Song YY; Zong CH; Hu Y; Xu XX; Lu HM
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):99-102. PubMed ID: 17445430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population.
    Hillilä MT; Färkkilä MA
    Aliment Pharmacol Ther; 2004 Aug; 20(3):339-45. PubMed ID: 15274671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of irritable bowel syndrome and associated factors according to the Rome III diagnostic criteria in a general population in Colombia].
    Gómez Alvarez DF; Morales Vargas JG; Rojas Medina LM; Mújica Oviedo SC; Camacho López PA; Rueda Jaimes GE
    Gastroenterol Hepatol; 2009; 32(6):395-400. PubMed ID: 19520461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevalence of irritable bowel syndrome in Veracruz City, Mexico: a community-based survey].
    Valerio-Ureña J; Vásquez-Fernández F; Jiménez-Pineda A; Cortázar-Benítez LF; Azamar-Jácome AA; Duarte-Velázquez ME; Torres-Medina V
    Rev Gastroenterol Mex; 2010; 75(1):36-41. PubMed ID: 20423781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unexpectedly low prevalence rates of IBS among adult Israeli Jews.
    Sperber AD; Shvartzman P; Friger M; Fich A
    Neurogastroenterol Motil; 2005 Apr; 17(2):207-11. PubMed ID: 15787941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in gastrointestinal symptoms according to gender in Rome II positive IBS and dyspepsia in a Latin American population.
    Schmulson M; Adeyemo M; Gutiérrez-Reyes G; Charúa-Guindic L; Farfán-Labonne B; Ostrosky-Solis F; Díaz-Anzaldúa A; Medina L; Chang L
    Am J Gastroenterol; 2010 Apr; 105(4):925-32. PubMed ID: 20179693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Quality of life at dyspepsia and irritable bowel syndrome: population-based studies].
    Reshetnikov OV; Kurilovich SA; Simonova GI; Pylenkova ED; Maliutina SK
    Eksp Klin Gastroenterol; 2010; (3):27-31. PubMed ID: 20496786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.